Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from ...
Veligrotug, an IGF-1R inhibitor, is under FDA Priority Review for thyroid eye disease based on positive phase 3 trial data.
Aims There is a paucity of literature concerning intractable diplopia. The aims of this study were to determine the incidence of intractable diplopia in the UK, identify the causes and any associated ...
Did you know your eyes can reveal diabetes, heart issues, or tumors? Discover which systemic diseases manifest through vision ...
When I was about 6 years old in the early ‘40s, my 16-year-old brother was sent to a sanitarium for tuberculosis patients. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback